Display options
Cite
Taniguchi-Ikeda M, Koyanagi-Aoi M, Maruyama T, et al. Restoration of the defect in radial glial fiber migration and cortical plate organization in a brain organoid model of Fukuyama muscular dystrophy. iScience. 2021;24(10):103140doi: 10.1016/j.isci.2021.103140.
Taniguchi-Ikeda, M., Koyanagi-Aoi, M., Maruyama, T., Takaori, T., Hosoya, A., Tezuka, H., Nagase, S., Ishihara, T., Kadoshima, T., Muguruma, K., Ishigaki, K., Sakurai, H., Mizoguchi, A., Novitch, B. G., Toda, T., Watanabe, M., & Aoi, T. (2021). Restoration of the defect in radial glial fiber migration and cortical plate organization in a brain organoid model of Fukuyama muscular dystrophy. iScience, 24(10), 103140. https://doi.org/10.1016/j.isci.2021.103140
Taniguchi-Ikeda, Mariko, et al. "Restoration of the defect in radial glial fiber migration and cortical plate organization in a brain organoid model of Fukuyama muscular dystrophy." iScience vol. 24,10 (2021): 103140. doi: https://doi.org/10.1016/j.isci.2021.103140
Taniguchi-Ikeda M, Koyanagi-Aoi M, Maruyama T, Takaori T, Hosoya A, Tezuka H, Nagase S, Ishihara T, Kadoshima T, Muguruma K, Ishigaki K, Sakurai H, Mizoguchi A, Novitch BG, Toda T, Watanabe M, Aoi T. Restoration of the defect in radial glial fiber migration and cortical plate organization in a brain organoid model of Fukuyama muscular dystrophy. iScience. 2021 Sep 17;24(10):103140. doi: 10.1016/j.isci.2021.103140. eCollection 2021 Oct 22. PMID: 34632335; PMCID: PMC8487058.
Copy Download .nbib Format: NLM
Share it on

iScience. 2021 Sep 17;24(10):103140. doi: 10.1016/j.isci.2021.103140. eCollection 2021 Oct 22.

Restoration of the defect in radial glial fiber migration and cortical plate organization in a brain organoid model of Fukuyama muscular dystrophy.

iScience

Mariko Taniguchi-Ikeda, Michiyo Koyanagi-Aoi, Tatsuo Maruyama, Toru Takaori, Akiko Hosoya, Hiroyuki Tezuka, Shotaro Nagase, Takuma Ishihara, Taisuke Kadoshima, Keiko Muguruma, Keiko Ishigaki, Hidetoshi Sakurai, Akira Mizoguchi, Bennett G Novitch, Tatsushi Toda, Momoko Watanabe, Takashi Aoi

Affiliations

  1. Department of Clinical Genetics, Fujita Health University Hospital, 1-98 Dengakugakubo, Kutsukake-chou, Toyoake, Aichi 470-1192, Japan.
  2. Division of Molecular Genetics, Institute for Comprehensive Medical Science, Fujita Health University, Toyoake, Aichi 470-1192, Japan.
  3. Department of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Hyogo 650-0017, Japan.
  4. Division of Advanced Medical Science, Graduate School of Science, Technology and Innovation, Kobe University, Kobe, Hyogo 650-0017, Japan.
  5. Department of iPS Cell Applications, Graduate School of Medicine, Kobe University, Kobe, Hyogo 650-0017, Japan.
  6. Center for Human Resource Development for Regenerative Medicine, Kobe University Hospital, Kobe, Hyogo 650-0017, Japan.
  7. Department of Chemical Science and Engineering, Graduate School of Engineering, Kobe University, Kobe, Hyogo 657-8501, Japan.
  8. Department of Clinical Application, Center for iPS Cell Research and Application, Kyoto University, Sakyo-ku, Kyoto 606-8507, Japan.
  9. Department of Pediatrics, Kyoto University Graduate School of Medicine, Sakyo-ku, Kyoto 606-8507, Japan.
  10. Department of Cellular Function Analysis, Research Promotion and Support Headquarters, Fujita Health University, Toyoake, Aichi 470-1192, Japan.
  11. Asubio Pharma Co., Ltd., Kobe, Hyogo 650-0047, Japan.
  12. Innovative and Clinical Research Promotion Center, Gifu University Hospital, Yanagido, Gifu 501-1194, Japan.
  13. Laboratory for Cell Asymmetry, RIKEN Center for Developmental Biology, Kobe, Hyogo 650-0047, Japan.
  14. Department of iPS Cell Applied Medicine, Graduate School of Medicine, Kansai Medical University, Hirakata, Osaka 573-1010, Japan.
  15. Department of Pediatrics, Tokyo Women's Medical University, School of Medicine, Shinjuku-ku, Tokyo 162-8666, Japan.
  16. Department of Personalized Cancer Immunotherapy, Mie University Graduate School of Medicine, Tsu, Mie 514-8507, Japan.
  17. Department of Neurobiology, David Geffen School of Medicine at the University of California, Los Angeles (UCLA), Los Angeles, CA 90095, USA.
  18. Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, UCLA, Los Angeles, CA, USA.
  19. Intellectual and Developmental Disabilities Research Center, UCLA, Los Angeles, CA 90095, USA.
  20. Department of Neurology, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo, 113-8655, Japan.
  21. Department of Anatomy and Neurobiology, School of Medicine, University of California, Irvine, Irvine, CA 92697, USA.
  22. Sue & Bill Gross Stem Cell Research Center, School of Medicine, University of California, Irvine, Irvine, CA 92697, USA.

PMID: 34632335 PMCID: PMC8487058 DOI: 10.1016/j.isci.2021.103140

Abstract

Fukuyama congenital muscular dystrophy (FCMD) is a severe, intractable genetic disease that affects the skeletal muscle, eyes, and brain and is attributed to a defect in alpha dystroglycan (αDG)

© 2021 The Author(s).

Keywords: Neuroscience; Pathophysiology; Tissue Engineering

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

  1. Nature. 2011 Oct 05;478(7367):127-31 - PubMed
  2. J Neurosci. 2010 Oct 27;30(43):14560-72 - PubMed
  3. Proc Natl Acad Sci U S A. 2013 Dec 10;110(50):20284-9 - PubMed
  4. Nature. 2013 Sep 19;501(7467):373-9 - PubMed
  5. Lancet. 2002 Nov 2;360(9343):1419-21 - PubMed
  6. Science. 2014 Aug 8;345(6197):688-93 - PubMed
  7. Neuromuscul Disord. 2010 Aug;20(8):524-30 - PubMed
  8. Brain Dev. 1981;3(1):1-29 - PubMed
  9. Acta Neuropathol. 1996;91(3):313-21 - PubMed
  10. Nat Methods. 2015 Jul;12(7):671-8 - PubMed
  11. Lancet. 2019 Nov 30;394(10213):2025-2038 - PubMed
  12. Mol Aspects Med. 2016 Oct;51:115-24 - PubMed
  13. Stem Cell Res. 2017 Dec;25:98-106 - PubMed
  14. Nature. 1998 Jul 23;394(6691):388-92 - PubMed
  15. Front Synaptic Neurosci. 2018 Jun 08;10:15 - PubMed
  16. J Neuropathol Exp Neurol. 2012 Dec;71(12):1047-63 - PubMed
  17. Cell Stem Cell. 2009 Jun 5;4(6):472-6 - PubMed
  18. Neurobiol Dis. 2005 Jun-Jul;19(1-2):208-17 - PubMed
  19. Genomics. 2002 Nov;80(5):482-6 - PubMed
  20. Nature. 2002 Jul 25;418(6896):417-22 - PubMed
  21. Biochem Biophys Res Commun. 2006 Jul 7;345(3):926-32 - PubMed
  22. Cell. 2011 Jul 8;146(1):18-36 - PubMed
  23. Curr Opin Cell Biol. 2018 Dec;55:8-16 - PubMed
  24. Cell. 2007 Nov 30;131(5):861-72 - PubMed
  25. Cell Stem Cell. 2008 Nov 6;3(5):519-32 - PubMed
  26. PLoS One. 2013 Apr 23;8(4):e61540 - PubMed
  27. Nat Methods. 2011 May;8(5):409-12 - PubMed
  28. Hum Mol Genet. 2009 Feb 15;18(4):621-31 - PubMed
  29. Hum Mol Genet. 2018 Apr 1;27(7):1174-1185 - PubMed
  30. Bioorg Med Chem. 2015 Dec 15;23(24):7661-70 - PubMed
  31. Acta Neuropathol Commun. 2013 Sep 06;1:58 - PubMed
  32. Cell Rep. 2016 Mar 8;14(9):2209-2223 - PubMed
  33. Dis Model Mech. 2018 Dec 19;11(12): - PubMed
  34. Cell Rep. 2017 Oct 10;21(2):517-532 - PubMed
  35. J Hum Genet. 2017 Nov;62(11):945-948 - PubMed

Publication Types